However, when oxantel pamoate is administered in combination with ALB, the efficacy (CR: 31.2%; ERR: 96%) [19,21] is similar to the results reported for ALB in combination with either MBD (CR: 46.1%; ERR: 93.2%) [22] or IVM (200 μg/kg) (CR: 37.9%; ERR: 91.1%), or IVM in combination with MBD (CR: 55.1%; ERR: 96.7%) [9]. This evidence concerns the gene ALB and Marchiafava-Bignami disease.